M. Razi Rafeeq, MD, a board-certified allergist and Anaphylaxis Community Expert (ACE) from Toledo, Ohio, recently testified before the Ohio House Education Committee in support of HB 296, legislation that allows schools to stock auto-injectable epinephrine to treat life-threatening allergic reactions, or anaphylaxis.
VIENNA, VA, JUNE 2, 2014 – You’re back at work after a relaxing vacation, and by noon your head aches and the nagging cough returns. Is it stress? A virus? Or could you be allergic to something in the office?
– Wherever Your Destination
When Diane, a 22-year-old graduate student at the University of Maryland, packed for a three-week study abroad course in Morocco last winter, she never thought she would need an epinephrine auto-injector.
Diane figured she had long outgrown her food allergies. She hadn’t had an allergic reaction to peanut since 2000 – when she was 9 years old.
Allergy immunotherapy gradually builds a person’s tolerance to specific allergens by exposing the patient to ever-increasing doses over a period of time – eventually reducing or eliminating symptoms. Read the rest of this entry »
U.S. Rep. Carol Shea-Porter (D-NH) envisions a day when people say, “There once was a disease called asthma.” She sees a time in the not-too-distant future when parents tell kids, “People actually used to die from eating peanut butter.”
What will it take to reach that day? A renewed emphasis on medical research, patient education, high-quality and ethical care, federal and community programs – and most of all, a commitment to patient safety. Read the rest of this entry »
Allergy and asthma medications are at the forefront of the U.S. Food and Drug Administration (FDA) agenda this year as the agency considers moving more drugs from prescription to over-the-counter (OTC) status.
Two medications recently considered were Nasacort®, the corticosteroid nasal spray approved for OTC use in late 2013, and Primatene HFA, an OTC asthma bronchodilator still under consideration at this time.
VIENNA, VA, MAY 2, 2014 – Patients and families with asthma, allergies and other health conditions now have access to a simple and free Prescription Assistance Program through Allergy & Asthma Network Mothers of Asthmatics (AANMA) offering savings of up to 75 percent on prescription medications, both brand and generic. Read the rest of this entry »
Research shows that children who attend an asthma camp have better asthma control the following year, are more likely to use daily preventive medication, and are 33 percent less likely to be hospitalized.
May 6-7, 2014
Join Allergy & Asthma Network Mothers of Asthmatics (AANMA) on Capitol Hill as we gather patients, families and health care professionals to talk with Congress in support of our common goal — to end the needless death and suffering due to asthma, allergies and related conditions.
Make plans to attend — and be the voice of change!
Allergy testing and immunotherapy schemes continue to pop up in primary care practices across the country, exposing patients and families to substandard diagnosis and treatment as well as raising the potential for fraud.